IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $354,489 | -6.7% | 7,815 | -15.6% | 0.00% | – |
| Q2 2023 | $379,938 | +19.2% | 9,260 | +3.8% | 0.00% | – |
| Q1 2023 | $318,694 | -36.4% | 8,917 | -33.1% | 0.00% | – |
| Q4 2022 | $501,000 | -70.7% | 13,331 | -65.6% | 0.00% | -100.0% |
| Q3 2022 | $1,711,000 | +306.4% | 38,703 | +240.0% | 0.00% | – |
| Q2 2022 | $421,000 | -9.9% | 11,384 | -10.2% | 0.00% | – |
| Q1 2022 | $467,000 | +59.4% | 12,682 | +31.7% | 0.00% | – |
| Q4 2021 | $293,000 | -19.9% | 9,627 | -11.7% | 0.00% | – |
| Q3 2021 | $366,000 | -7.3% | 10,899 | +9.8% | 0.00% | – |
| Q2 2021 | $395,000 | -39.4% | 9,925 | -31.4% | 0.00% | – |
| Q1 2021 | $652,000 | -24.6% | 14,478 | -5.1% | 0.00% | – |
| Q4 2020 | $865,000 | +73.7% | 15,259 | +45.2% | 0.00% | – |
| Q3 2020 | $498,000 | -23.7% | 10,512 | -4.9% | 0.00% | – |
| Q2 2020 | $653,000 | +38.3% | 11,058 | +11.0% | 0.00% | – |
| Q1 2020 | $472,000 | -16.2% | 9,960 | +7.0% | 0.00% | – |
| Q4 2019 | $563,000 | +14.9% | 9,305 | +13.5% | 0.00% | – |
| Q3 2019 | $490,000 | -3.2% | 8,197 | +4.2% | 0.00% | – |
| Q2 2019 | $506,000 | -34.0% | 7,868 | -16.8% | 0.00% | – |
| Q1 2019 | $767,000 | +54.3% | 9,454 | +3.0% | 0.00% | – |
| Q4 2018 | $497,000 | -28.2% | 9,183 | -31.5% | 0.00% | – |
| Q3 2018 | $692,000 | -88.6% | 13,406 | -90.8% | 0.00% | -100.0% |
| Q2 2018 | $6,053,000 | +88.1% | 145,296 | +99.0% | 0.00% | +200.0% |
| Q1 2018 | $3,218,000 | +227.4% | 73,025 | +273.8% | 0.00% | – |
| Q4 2017 | $983,000 | +115.6% | 19,535 | +117.6% | 0.00% | – |
| Q3 2017 | $456,000 | -52.2% | 8,978 | -52.1% | 0.00% | – |
| Q2 2017 | $953,000 | +364.9% | 18,752 | +267.3% | 0.00% | – |
| Q1 2017 | $205,000 | -72.0% | 5,105 | -66.6% | 0.00% | – |
| Q4 2016 | $731,000 | -76.8% | 15,287 | -70.0% | 0.00% | -100.0% |
| Q4 2015 | $3,156,000 | – | 50,962 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |